FNY Investment Advisers’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,000
Closed -$22K 770
2023
Q4
$22K Buy
+10,000
New +$23.8K 0.02% 257
2021
Q1
Sell
-34,599
Closed -$587K 925
2020
Q4
$587K Buy
34,599
+17,299
+100% +$426K 0.16% 129
2020
Q3
$642K Buy
+17,300
New +$542K 0.27% 83
2019
Q1
Sell
-1,500
Closed -$12K 843
2018
Q4
$12K Buy
+1,500
New +$17.2K ﹤0.01% 387

Other funds holding MESO

FNY Investment Advisers's MESO Position: Q1 2024 in Review

FNY Investment Advisers sold out of Mesoblast (MESO) in Q1 2024, closing a stake of 10,000 shares — an estimated $22K sold.

FNY Investment Advisers first reported a position in MESO in Q4 2018 and held it in 4 quarters. The position peaked at $642K in Q3 2020. 26 funds tracked by Wall St. Rank hold MESO as of Q1 2024.

  • FNY Investment Advisers reported no remaining Mesoblast position as of Q1 2024 after selling out during the quarter.
  • FNY Investment Advisers sold 10,000 Mesoblast shares in Q1 2024, an estimated $22K.
  • FNY Investment Advisers first reported a position in Mesoblast in Q4 2018 and held it in 4 quarters.
  • FNY Investment Advisers's Mesoblast position peaked at $642K in Q3 2020.
  • 26 funds tracked by Wall St. Rank held Mesoblast as of Q1 2024.

Based on FNY Investment Advisers's 13F filing for Q1 2024, filed 3 May 2024.